Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suma Vijayakumar"'
Autor:
Afsheen Raza, Reyad Mohsen, Aladdin Kanbour, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar, Shereena Hydrose, Kirti S. Prabhu, Aisha Khamis Al-Suwaidi, Varghese Philipose Inchakalody, Maysaloun Merhi, Dina M. Abo El-Ella, Melissa Annrose Tauro, Shayista Akbar, Issam Al-Bozom, Wafa Abualainin, Rajaa Al-Abdulla, Shaza Abu Sirriya, Suparna Hassnad, Shahab Uddin, Mohamed Izham Mohamed Ibrahim, Ussama Al Homsi, Said Demime
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNon-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide. Immune checkpoint inhibitors (ICIs) including anti-PD-1 and anti-PD-L1 antibodies, have significantly changed the treatment outcome
Externí odkaz:
https://doaj.org/article/233a7d8ebbf84bb5961b63277ff4797e
Autor:
Shayista Akbar, Afsheen Raza, Reyad Mohsin, Aladdin Kanbour, Shahnaz Qadri, Aijaz Parray, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar, Maysaloun Merhi, Shereena Hydrose, Varghese Philipose Inchakalody, Rajaa Al-Abdulla, Wafa Abualainin, Shaza Abu Sirriya, Issam Al-Bozom, Shahab Uddin, Omar Muhammad Khan, Mohamed Izham Mohamed Ibrahim, Ussama Al Homsi, Said Dermime
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Immune checkpoint inhibitors (ICIs) including anti-PD-1 and anti-PD-L1 antibodies, have significantly changed the treatment outcomes of NSCLC patients with better overall survival. However, 15-40% of the patients still fail to respond to ICIs therapy
Externí odkaz:
https://doaj.org/article/207168b5e2c245d9b4aedca837e00d72
Autor:
Said Dermime, Maysaloun Merhi, Afsheen Raza, Shereena Hydrose, Shahab Uddin, Varghese Inchakalody, Mohammed Ussama Al Homsi, Reyad Mohsen, Aladdin Kanbour, Abdul Rehman Zar Gul, Anite Philip, Suma Vijayakumar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/c3cb8fbebb5545dba4b6cdfe363fc67c
Autor:
Suma Vijayakumar, Said Dermime, Varghese Inchakalody, Shereena Hydrose, Reyad Mohsen, Aladdin Kanbour, Shahab Uddin, Anite Philip, Maysaloun Merhi, Abdul Rehman Zar Gul, Afsheen Raza, Mohammed Ussama Al Homsi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThere is limited data on the predictive biomarkers of response to immune checkpoint blockade (ICB) treatment of non-small cell lung cancer (NSCLC) patients. The main aim of this prospective study was to understand the utility of pre-treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2879d9b5f59601e84a6fa485e1191b5
https://doaj.org/article/c3cb8fbebb5545dba4b6cdfe363fc67c
https://doaj.org/article/c3cb8fbebb5545dba4b6cdfe363fc67c
Publikováno v:
Journal of Nursing Education and Practice. 9:6
Cancer related fatigue (CRF) is one among the common distressing symptoms experienced by cancer patients. Evidence showed that exercise interventions are effective in decreasing CRF. This review is to evaluate the evidence of the effectiveness of exe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1f06e6403226c03d5653173ac0e401e
https://doi.org/10.5430/jnep.v9n1p6
https://doi.org/10.5430/jnep.v9n1p6